Medical Journals

Mechanical Evaluation of Bone Samples Following Alendronate Therapy in Healthy Male Dogs.

Authors:
  • Fischer Kenneth J
  • Vikoren Thomas H H
  • Ney Susan
  • Kovach Charles
  • Hasselman Carl
  • Agrawal Mauli
  • Rubash Harry
  • Shanbhag Arun S

From: Department of Mechanical Engineering, University of Kansas, Lawrence, Kansas 66045-7609, USA. fischer@ku.edu

Journal of biomedical materials research. Part B, Applied biomaterials

  • Publish Date: Jan 2006
  • ISSN: 1552-4973
  • Volume: 76
  • Issue: 1
  • Pages: 143-8
  • Medium: Print
  • Language: English
  • Citation (JAMA): Fischer Kenneth J, Vikoren Thomas H H, Ney Susan, et al. Mechanical Evaluation of Bone Samples Following Alendronate Therapy in Healthy Male Dogs.. J. Biomed. Mater. Res. Part B Appl. Biomater. Jan 2006;76:143-8

Abstract

Alendronate and other bisphosphonates are clinically efficacious in treating postmenopausal osteoporosis, Paget’s disease and hypercalcemia associated with malignancy. Because bisphosphonates are being considered for use in younger patients with joint replacements to prevent osteolysis, and for stress fracture prophylaxis in military recruits, it is important to know how bisphosphonate therapy affects healthy bone. We sought to determine whether bones from healthy male dogs exhibit alterations in structural or mechanical properties following alendronate treatment for 23 weeks. We tested trabecular tissue samples in compression and determined tissue ash density. We tested whole long bones in bending and torsion. For trabecular samples, we evaluated trabecular modulus, strength, and density. For whole bone specimens, we compared structural stiffness and ultimate load. We found no significant differences in any measure, between canines treated with alendronate for 23 weeks and controls, although we found consistent trends toward higher properties in the treated group. Correlation analysis revealed significant relationships between stiffness and strength measures for each mechanical test. Our results indicate bisphosphonate treatment in healthy canines does not weaken the properties of bone. The trends indicate a slight positive overall effect of alendronate treatment on the mechanical properties of healthy canine bone.

Mesh Headings (Keywords): Alendronate, Animals, Biomechanics, Bone and Bones, Dogs, Male


Check for Full Text / PubMed Unique Identifier (PMID): 16047323


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.